Covid-19 Booster Shot Debated in US Amid Resurgence

US is witnessing a resurgence in Covid-19 cases. However, there are some states that are faring better than previous weeks and booster shot against Covid-19 is being debated in the country.

The federal government's push to introduce //widespread Covid-19 booster shots faced a test as a Food and Drug Administration (FDA) advisory panel met on Friday to weigh evidence on the extra jabs, a topic that has divided health officials, Xinhua news agency reported.

COVID-19 in Telangana: Daily Count Falls Below 1K-mark
For the first time in more than a month, the daily count of COVID-19 cases in Telangana came down below 1,000-mark as the state reported 983 new cases on Monday.

‘Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC) disagree about the use of booster vaccine. However, US health officials, some other countries and vaccine makers have said boosters were needed.’

Tweet it Now

The outside panel of about 20 scientific advisers reviewed information about the Pfizer Inc. and BioNTech SE vaccine's declining protection against Covid-19 over time and on how people tolerated additional doses.

Pfizer has asked regulators to clear booster shots for people 16 years and older, and the FDA, which this week said all the shots cleared for use in the country remain effective without boosters.

While US health officials, some other countries and vaccine makers have said boosters were needed, many scientists, including some inside the FDA and the CDC, disagree.

Antibiotic Prescribing Pattern Post COVID-19
A new study examines the antibiotic prescribing pattern among general practitioners following COVID-19 restrictions.

The FDA panel then voted to recommend Covid-19 booster shots for Americans 65 and older and those at high risk of severe illness, but rejecting a broader use.

"Anything short of a full-throated endorsement could complicate the Biden administration's plan to begin distributing extra shots next week to bolster immunity among the vaccinated and counter highly transmissible variants of the virus such as Delta," The Wall Street Journal said in a report on Friday.

COVID-19 in India: 30,773 New Coronavirus Cases, 309 Deaths
In India in the last 24 hours, 30,773 new Covid-19 cases and 309 deaths have been recorded. With the new fatalities, the country's cumulative death toll increased to 4,44,838.

Source-IANS

Does Blood Plasma Therapy Help Seriously Ill COVID-19 Patients?
A new clinical trial on convalescent plasma and COVID-19 patients may provide conflicting results that need to be analyzed with other studies for more information.